Safety and immunogenicity of an enterotoxigenic Escherichia coli vaccine patch containing heat-labile toxin: use of skin pretreatment to disrupt the stratum corneum
about
Vaccines for preventing enterotoxigenic Escherichia coli (ETEC) diarrhoeaTranscutaneous immunization with heat-labile enterotoxin: development of a needle-free vaccine patchNew Developments in Traveler's DiarrheaTransdermal influenza immunization with vaccine-coated microneedle arrays.Concomitant enterotoxigenic Escherichia coli infection induces increased immune responses to Vibrio cholerae O1 antigens in patients with cholera in Bangladesh.The extent of the uptake of plasmid into the skin determines the immune responses induced by a DNA vaccine applied topically onto the skin.Facilitation of transcutaneous drug delivery and vaccine immunization by a safe laser technology.The A subunit of Escherichia coli heat-labile enterotoxin functions as a mucosal adjuvant and promotes IgG2a, IgA, and Th17 responses to vaccine antigensRecent advances in understanding enteric pathogenic Escherichia coli.Vaccines against enterotoxigenic Escherichia coli.Expert review of the evidence base for prevention of travelers' diarrhea.Evaluating the A-Subunit of the Heat-Labile Toxin (LT) As an Immunogen and a Protective Antigen Against Enterotoxigenic Escherichia coli (ETEC).Antibody against recombinant heat labile enterotoxin B subunit (rLTB) could block LT binding to ganglioside M1 receptorCurrent Progress in Developing Subunit Vaccines against Enterotoxigenic Escherichia coli-Associated Diarrhea.Transcutaneous drug delivery by liposomes using fractional laser technology.Needle-free vaccine delivery.The science of adjuvants.Transcutaneous delivery and thermostability of a dry trivalent inactivated influenza vaccine patchCutaneous delivery of prophylactic and therapeutic vaccines: historical perspective and future outlook.Selective removal of stratum corneum by microdermabrasion to increase skin permeability.Mucosal vaccines: novel advances in technology and delivery.Toxin-mediated effects on the innate mucosal defenses: implications for enteric vaccines.Recent progress toward an enterotoxigenic Escherichia coli vaccine.Progress and hurdles in the development of vaccines against enterotoxigenic Escherichia coli in humans.Transcutaneous vaccines--current and emerging strategies.Vaccination for the expatriate and long-term traveler.Design and characterization of a chimeric multiepitope construct containing CfaB, heat-stable toxoid, CssA, CssB, and heat-labile toxin subunit B of enterotoxigenic Escherichia coli: a bioinformatic approach.The Current State of Epicutaneous Immunotherapy for Food Allergy: a Comprehensive Review.A Chimeric protein of CFA/I, CS6 subunits and LTB/STa toxoid protects immunized mice against enterotoxigenic Escherichia coli.Enhancing tumor specific immune responses by transcutaneous vaccination.
P2860
Q24201328-F58C4513-5D9B-487F-81B3-6971E493E3D8Q28252883-6BEEB3C7-00D4-41BA-A574-017DDF540E91Q28387036-5D794F4C-BCB3-47AF-8606-43BCDF87E201Q33416417-E0237949-A590-4069-AE22-834B2AE5FB40Q33826000-C913214E-9187-4961-97C2-7EB794F4E5DEQ34025333-EF637AEE-104A-4918-B9B8-F4AD6BB6E015Q34133549-14C88B69-70C2-44B4-AA62-DE72CBC0CBFCQ34270342-8AD6543B-CE00-479B-91A6-C0B48E4D7159Q34375210-D99815FC-4F6D-40BA-BF5D-4539DBAC9750Q34594874-A2B16A7E-2F84-44D7-8136-054CD75B9B67Q34987670-4B7FC254-695F-4760-B368-D54D0E416263Q35754880-4709D393-80D1-4EEF-A5AE-099D61D723FEQ35757910-F9F1AA39-5E80-46FF-9097-498055547B78Q35998767-7EB74D1E-DB0A-476E-9E2C-D20D6B4E17B6Q36227719-568DCBC8-3543-48DB-94DB-1AC0A7FF8600Q36945838-C7DCDEE4-FC03-4C00-A1FE-9BADA6BE3C00Q36968250-F32E3672-AF26-449F-9F21-B4F3A6E7974BQ37087659-4A0B877B-5E04-40E1-BC9A-C7BA05081532Q37316009-5AD13006-E0F1-4A47-A4BE-B615663E6954Q37316218-2B958933-50DB-429C-BA1D-40BFB8A8FCB0Q37559647-F746FA62-3DA7-4767-BE66-D5AEC30D7FBEQ37593785-6911A919-A764-4A51-8CAA-A924C6B5600DQ38006998-59CCA127-DAA8-473F-88F4-8EB7A70DE6EDQ38032878-CAA544C5-25A1-449A-80E6-433DE258F111Q38073800-D0706814-ED74-40D4-9A32-8DF3891B15E1Q38208436-3ACF288D-981A-4809-B6A3-B618FAF67A23Q43472318-1827B105-1190-42D3-87FF-10C1C27BE41DQ47696103-81EDD52D-40BC-4BE6-820E-A445DF849FCDQ47753043-CE273995-7F6D-4579-8B6C-19CFF3149B60Q49932505-28E96C09-8762-432C-8605-EF2ADB924616
P2860
Safety and immunogenicity of an enterotoxigenic Escherichia coli vaccine patch containing heat-labile toxin: use of skin pretreatment to disrupt the stratum corneum
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Safety and immunogenicity of a ...... to disrupt the stratum corneum
@ast
Safety and immunogenicity of a ...... to disrupt the stratum corneum
@en
type
label
Safety and immunogenicity of a ...... to disrupt the stratum corneum
@ast
Safety and immunogenicity of a ...... to disrupt the stratum corneum
@en
prefLabel
Safety and immunogenicity of a ...... to disrupt the stratum corneum
@ast
Safety and immunogenicity of a ...... to disrupt the stratum corneum
@en
P2093
P2860
P356
P1476
Safety and immunogenicity of a ...... to disrupt the stratum corneum
@en
P2093
A Louis Bourgeois
Christina P Villar
David C Flyer
Gregory M Glenn
Robert M Lavker
Robin McKenzie
Sarah A Frech
P2860
P304
P356
10.1128/IAI.01740-06
P407
P577
2007-01-29T00:00:00Z